lobbying_filings_raw: fa6dfd70-58b1-4fda-9ae3-31f9a7ea52ea
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| fa6dfd70-58b1-4fda-9ae3-31f9a7ea52ea | Q2 | 3071 | AMERICAN PHARMACISTS ASSOCIATION | 103628 | AMERICAN PHARMACISTS ASSOCIATION | 2020 | second_quarter | 2020-07-10T12:21:58.880000-04:00 | 34000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/fa6dfd70-58b1-4fda-9ae3-31f9a7ea52ea/", "filing_uuid": "fa6dfd70-58b1-4fda-9ae3-31f9a7ea52ea", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2020, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/fa6dfd70-58b1-4fda-9ae3-31f9a7ea52ea/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "34000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Alicia Kerry J. Mica", "dt_posted": "2020-07-10T12:21:58.880000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "2215 CONSTITUTION AVENUE, NW", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20037", "registrant": {"id": 3071, "url": "https://lda.senate.gov/api/v1/registrants/3071/", "house_registrant_id": 31620, "name": "AMERICAN PHARMACISTS ASSOCIATION", "description": null, "address_1": "2215 CONSTITUTION AVENUE, NW", "address_2": null, "address_3": null, "address_4": null, "city": "WASHINGTON", "state": "DC", "state_display": "District of Columbia", "zip": "20037", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "DOUGLAS HUYNH", "contact_telephone": "+1 202-429-7573", "dt_updated": "2026-01-26T09:17:08.917208-05:00"}, "client": {"id": 103628, "url": "https://lda.senate.gov/api/v1/clients/103628/", "client_id": 12, "name": "AMERICAN PHARMACISTS ASSOCIATION", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-14"}, "lobbying_activities": [{"general_issue_code": "MAN", "general_issue_code_display": "Manufacturing", "description": "HR 6080 - Preventing Drug Shortages Act. To amend the Federal Food, Drug, and Cosmetic Act to reduce drug shortages, and for other purposes.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 66187, "prefix": null, "prefix_display": null, "first_name": "ALICIA", "nickname": null, "middle_name": "KERRY J.", "last_name": "MICA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "H.R. 2482/S. 2074 Mainstreaming Addiction Treatment Act of 2019-\nTo amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V (such as buprenorphine) for maintenance or detoxification treatment, and for other purposes.\nH.R. 6800 - This bill responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 66187, "prefix": null, "prefix_display": null, "first_name": "ALICIA", "nickname": null, "middle_name": "KERRY J.", "last_name": "MICA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CSP", "general_issue_code_display": "Consumer Issues/Safety/Products", "description": "HR 5663 - \"Safeguarding Therapeutics Act\". To amend the Federal Food, Drug, and Cosmetic Act to give authority to the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to destroy counterfeit devices.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 66187, "prefix": null, "prefix_display": null, "first_name": "ALICIA", "nickname": null, "middle_name": "KERRY J.", "last_name": "MICA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "EDU", "general_issue_code_display": "Education", "description": "HR 6699 - To establish a commission to determine essential employment during the COVID-19 crisis period and provide loan repayment and education credit to workers employed in such essential employment during such crisis, and for other purposes.\nHR 6433 - To provide an exclusion from gross income for certain qualified first responders.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 66187, "prefix": null, "prefix_display": null, "first_name": "ALICIA", "nickname": null, "middle_name": "KERRY J.", "last_name": "MICA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "H.R. 789 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies.\nH.R. 803 - This bill prohibits Medicare prescription drug plan sponsors from retroactively reducing payment on clean claims submitted by pharmacies. (A \"clean claim\" is a Medicare claim that is free of defects such as incomplete documentation.)\nH.R. 1034 - Phair Pricing Act of 2019; To amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program\nS. 640 - To amend title XVIII of the Social Security Act to require pharmacy-negotiated price concessions to be included in negotiated prices at the point-of-sale under part D of the Medicare program, and for other purposes.\nS. 476 - Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2019 - To amend titles XI and XVIII of the Social Security Act to provide greater transparency of discounts provided by drug manufacturers.\nS. 476 - Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2019 - To amend titles XI and XVIII of the Social Security Act to provide greater transparency of discounts provided by drug manufacturers.\nH.R. 3 Lower Drug Costs Now Act of 2019-To establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes.\nS.2543 Prescription Drug Pricing Reduction Act of 2019 -To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.\nHR 5304 PBM Transparency in Prescription Drug Cost Act - \nTo amend title XXVII of the Public Health Service Act to require health plan oversight of pharmacy benefit manager service\nHR 5442 - Lowest Price for Patients Act - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to require pharmacies to disclose any differential between the cost of a prescription drug based on whether certain individuals use prescription drug coverage to acquire such drug, and for other purposes.\nS. 3129 - To provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, and for other purposes.\nHR 19 - To provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, the Medicaid program under title XIX of such Act, the Food and Drug Administration, and for other purposes. Lower Costs, More Cures Act of 2019.\nHR 3 -To establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 66187, "prefix": null, "prefix_display": null, "first_name": "ALICIA", "nickname": null, "middle_name": "KERRY J.", "last_name": "MICA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |